Selected advances in therapy of urologic cancer--luteinizing hormone releasing hormone (LHRH) and biologic response modifier (BUR).

Javadpour, N

Selected advances in therapy of urologic cancer--luteinizing hormone releasing hormone (LHRH) and biologic response modifier (BUR). [electronic resource] - Progress in clinical and biological research 1988 - 27-38 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article

0361-7742


Adenocarcinoma--pathology
Buserelin--administration & dosage
Clinical Trials as Topic
Delayed-Action Preparations
Goserelin
Humans
Injections, Subcutaneous
Interleukin-2--therapeutic use
Male
Orchiectomy
Prostatic Neoplasms--pathology
Random Allocation
Recombinant Proteins--therapeutic use